Ursodeoxycholic acid, also known as ursodiol (USAN) and the abbreviation UDCA, from the root-word for bear urso, as bear bile contains the substance, is one of the secondary bile acids, which are metabolic byproducts of intestinal bacteria. Ursodeoxycholic acid can be chemically synthesized and is marketed under multiple trade names, including Actigall, BILIVER, Coric, Deursil, Egyurso, Udiliv, UDOXYL, Urso, Urso Forte, Ursocol, Ursofalk, Ursosan and Ursoserinox. Primary bile acids are produced by the liver and stored in the gall bladder. When secreted into the intestine, primary bile acids can be metabolized into secondary bile acids by intestinal bacteria. Primary and secondary bile acids help the body digest fats. Ursodeoxycholic acid helps regulate cholesterol by reducing the rate at which the intestine absorbs cholesterol molecules while breaking up micelles containing cholesterol. Because of this property, ursodeoxycholic acid is used to treat (cholesterol) gallstones non-surgically. It is also used to relieve itching in pregnancy for some women who suffer obstetric cholestasis.
Access Full Report With TOC: http://www.orbisresearch.com/reports/index/global-ursodeoxycholic-acid-market-outlook-2016-2021
This report provides detailed analysis of worldwide markets for Ursodeoxycholic Acid from 2011-2015 and provides extensive market forecasts 2016-2021 by region/country and subsectors. It covers the key technological and market trends in the Ursodeoxycholic Acid market and further lays out an analysis of the factors influencing the supply/demand for Ursodeoxycholic Acid, and the opportunities/challenges faced by industry participants. It also acts as an essential tool to companies active across the value chain and to the new entrants by enabling them to capitalize the opportunities and develop business strategies.
GCC’s report, Global Ursodeoxycholic Acid Market Outlook 2016-2021, has been prepared based on the synthesis, analysis, and interpretation of information about the global Ursodeoxycholic Acid market collected from specialized sources. The report covers key technological developments in the recent times and profiles leading players in the market and analyzes their key strategies. The competitive landscape section of the report provides a clear insight into the market share analysis of key industry players. The major players in the global Ursodeoxycholic Acid market are ICE, Mitsubishi Tanabe Pharma, Daewoong Bio, PharmaZell, Zhongshan Belling, Changde Yungang, among others.
The report provides separate comprehensive analytics for the North America, Europe, Asia-Pacific, Middle East and Africa and Rest of World. In this sector, global competitive landscape and supply/demand pattern of Ursodeoxycholic Acid industry has been provided.
Purchase a copy of this report @ http://www.orbisresearch.com/contact/purchase/330465
Major Parts from Table of Content:
Part 1. Exclusive Summary
Part 2. Methodology
Part 3. Introduction
Part 4. Market Landscape
Part 5. Segmentation by Products
Part 6. Segmentation by End-users
Part 7. Geographical Segmentation
Part 8. Market Forecast
Part 9. Company Profiles
Part 10. Market Dynamics
Part 11. Competitive Landscape
Part 12. Appendix
Ask for Sample report @ http://www.orbisresearch.com/contacts/request-sample/330465
Orbis Research (orbisresearch.com) is a single point aid for all your market research requirements. We have vast database of reports from the leading publishers and authors across the globe. We specialize in delivering customized reports as per the requirements of our clients. We have complete information about our publishers and hence are sure about the accuracy of the industries and verticals of their specialization. This helps our clients to map their needs and we produce the perfect required market research study for our clients.
Senior Manager – Client Engagements
4144N Central Expressway,
Suite 600, Dallas,
Texas – 75204, U.S.A.
Phone No.: +1 (214) 884-6817; +912064101019